| 
Results for over chiron. Search took 0.97 seconds.
Mexico's Demanding Road Rally Re-Imagines Lincoln, Mercedes, Porsche Victories
in Classical Drives, on October 21, 2007
...lby; Tony Bettenhausen and Jerry Unser from open wheel racing; future F1 champion Phil Hill; Louis Chiron from France; Italians Alberto Ascari, Piero Taruffi, Umberto Maglioli and Felice Bonetto. Ever...
SJBC - F&R Legal Breakfast Workshop: Litigation Avoidance
in The Biotech Weblog, on August 26, 2006
...gation and technology law. The workshop will tackle how life science companies such as Biogen Idec, Chiron, and Merck , have all faced difficult investigations and/or cases in the courts. The se...
Novartis Bids for NeuTec, Expands Into Hospital Anti-Infectives
in The Biotech Weblog, on June 8, 2006
...is could be just the latest of the many acquisitions Novartis made in the last year, starting with Chiron Vaccines in November last year, and the most recent of which is this week's aquisition ...
Top 20 Molecular Millionaires
in The Biotech Weblog, on May 31, 2006
...hur Levinson (photo). Here's the full list, ranked according to their biotech-derived riches:
Over $300 Million
1. Arthur Levinson, Ph.D., Genentech
Over $250 Million
2. John Martin, Ph... ...x, Ph.D., Icos
19. Dominic P. Behand, Ph.D., Arena Pharmaceutical
20. Edward Penhoet, Ph.D., Chiron
If you want to know more about these millionaires and their company's pipeline, read t...
Novartis Receives $220M Grant To Develop Cell-Culture Derived Flu Vaccine
in The Biotech Weblog, on May 5, 2006
...nza vaccine and to respond rapidly in the event of an influenza pandemic. The grant is part of the government plan to reach the capacity to produce 600 million doses of pandemic influenza vaccine with... ...t capacity."
Novartis' vaccine cadidate is developed and produced in Marburg, Germany by Chiron , which Novartis took over earlier this year . Clinical studies are currently ongoing both i...
Chiron Files For EU Approval For Pandemic Flu Vaccine
in The Biotech Weblog, on February 28, 2006
...ines still in development.
Earlier this week, Chiron entered into a supply contract with the UK government (for government supply, not for general sale) for its pre-pandemic influenza vaccine for ... ... Chiron Corp is seeking approval from the European Medicines Agency (EMEA) for its pandemic influenza vaccine. The application for a fast-track approval is based on a so-called 'core dossier'...
Polio Vaccination Program Aid Bird Flu Info-Campaign in Nigeria
in The Biotech Weblog, on February 13, 2006
...ey ingredients of a potential solution to the pandemic threat," said Howard Pien, president of Chiron Corp. The California biotech firm has an adjuvant , an emulsion called MF59 whose main con...
CSL Limited Enters Flu Vaccine Market
in The Biotech Weblog, on February 7, 2006
...tplace, considering that the other big pharma companies such as Sanofi pasteur, GlaxoSmithKline and Chiron are revving up their productions. MedImmune even had a nasal spray version of the flu vaccin...
Novartis Receives European Commission Approval To Acquire Chiron
in The Biotech Weblog, on February 7, 2006
...artis announced yesterday that the European Union antitrust regulators approved of its takeover of Chiron Corp. When I first blogged about the takeover here in this weblog, I thought it was... ...nnounced yesterday that the European Union antitrust regulators approved of its takeover of Chiron Corp. When I first blogged about the takeover here in this weblog, I thought it was a done ...
Will Novartis Outbid Crucell for Berna Biotech?
in The Biotech Weblog, on December 19, 2005
...
Following its announcement of intending a full takeover of Chiron Vaccines , Swiss pharma giant Novartis considers acquiring another Swiss biotech company, Berna Biotech AG , to complement it... ...
Following its announcement of intending a full takeover of Chiron Vaccines , Swiss pharma giant Novartis considers acquiring another Swiss biotech company, Berna Biotech AG , to complement it...
Novartis Takes Over Chiron Corp
in The Biotech Weblog, on November 7, 2005
... Last week, Swiss pharmaceutical giant Novartis agreed to completely take over American vaccine maker Chiron Corp. Novartis paid $45 a share, shelling out $5.1 billion to acquire the remaining 58%... ...t week, Swiss pharmaceutical giant Novartis agreed to completely take over American vaccine maker Chiron Corp. Novartis paid $45 a share, shelling out $5.1 billion to acquire the remaining 58% of th...
Latest On Avian Flu Vaccines
in The Biotech Weblog, on October 30, 2005
...
Chiron 's flu vaccine against H9N2 avian influenza strain showed promising results in its clinical trials:
All vaccine formulations containing the adjuvant MF59 proved highly immunogeni...
Novartis Offers $4.5B for Complete Takeover of Chiron
in The Biotech Weblog, on September 1, 2005
... Novartis AG said it's offering $40 a share for the 57.8% it doesn't already own in Chiron . According to Novartis spokesman John Gilardi,
"Novartis believes this will put Chiron i...